MONDAY, Oct. 28, 2024 (HealthDay News) — McDonald’s Quarter Pounder beef patties have tested negative for E. coli contamination as an outbreak that has sickened 75 people in 13 states continues, the company announced Sunday. Federal health officials had already identified slivered onions that had been used on the burgersContinue Reading

FRIDAY, Oct. 25, 2024 (HealthDay News) — An outbreak of E. coli illness linked to onions used in McDonald’s Quarter Pounders has expanded to now include 75 cases across 13 states, U.S. health officials announced Friday. That’s up from 49 cases in 10 states reported on Monday. The three newContinue Reading

FRIDAY, Oct. 25, 2024 (HealthDay News) — With onions from one supplier implicated as the source of E. coli illness linked to McDonald’s Quarter Pounders, other fast food chains are now pulling the onions from their menus. Representatives for Burger King, Taco Bell, KFC and Pizza Hut all told NBC NewsContinue Reading

FRIDAY, Oct. 24, 2024 (HealthDay News) — Certain gut microbes might be linked to a person’s risk of developing Parkinson’s disease, a new study suggests. People prescribed multiple courses of penicillin antibiotics have a modestly lower risk of developing Parkinson’s, researchers found. Those antibiotics might be affecting bacterial populations inContinue Reading

THURSDAY, Oct. 24, 2024 (HealthDay News) — Just days after an E. coli outbreak tied to McDonald’s Quarter Pounders was first announced, a company producing onions used in the burgers said it has issued a recall for its diced, peeled and whole onions. The onions were produced at Taylor FarmsContinue Reading

WEDNESDAY, Oct. 23, 2024 (HealthDay News) — An E. coli outbreak tied to McDonald’s Quarter Pounders has sickened 49 people in 10 states, killing one and landing 10 more in the hospital. Most of the illnesses have been reported in Colorado and Nebraska, and one child developed a serious complicationContinue Reading

FRIDAY, Sept. 27, 2024 (HealthDay News) — An experimental monoclonal antibody treatment appears to ease the digestive disorder ulcerative colitis in patients who’ve failed other medications, a new trial shows. The treatment, tulisokibart, spurred remission of symptoms in more than a quarter of patients, compared to only 1.5% of thoseContinue Reading